# High-Dose Dual Therapy for H. Pylori Eradication (RETRO-HP Study)

> **NCT07121205** · — · COMPLETED · sponsor: **Liyueyue** · enrollment: 1600 (actual)

## Conditions studied

- HELICOBACTER PYLORI INFECTIONS

## Interventions

- **OTHER:** This study is a retrospective study, and all data have been collected in advance with no active intervention required.

## Key facts

- **NCT ID:** NCT07121205
- **Lead sponsor:** Liyueyue
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-07-20
- **Target enrollment:** 1600 (ACTUAL)
- **Last updated:** 2025-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07121205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07121205, "High-Dose Dual Therapy for H. Pylori Eradication (RETRO-HP Study)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07121205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*